Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background and aim: Nonalcoholic fatty liver disease (NAFLD) may be associated with sarcopenia. This study aims to determine whether sarcopenia is independently associated with NAFLD and advanced fibrosis. Participants and methods: Cross-sectional data from 11 325 participants in the third National Health and Nutrition Examination Survey were analyzed. NAFLD was defined as the presence of hepatic steatosis from the ultrasound. Sarcopenia was defined as the skeletal muscle index. Results: NAFLD was more common in participants with sarcopenia than in those without (46.7 vs. 27.5%). Univariate analysis showed that sarcopenia was associated with NAFLD [odds ratio (OR): 2.31; 95% confidence interval (CI): 2.01–2.64], which remained significant after adjustment for age, sex, ethnicity, metabolic risk factors (OR: 1.24; 95% CI: 1.03–1.48). This finding persisted after adjustment for C-reactive protein as a marker of chronic inflammation. NAFLD-associated advanced fibrosis was more common in participants with sarcopenia than in those without (7.8 vs. 1.6%). Sarcopenia was associated with NAFLD-associated advanced fibrosis independent of metabolic risk factors (OR: 1.79; 95% CI: 1.18–2.72). Conclusion: Sarcopenia was independently associated with increased odds of NAFLD and NAFLD-associated advanced fibrosis independent of well-defined risk factors. Interventions to strengthen muscle mass may reduce the burden of NAFLD and advanced fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
Estimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis
McPherson, S., Hardy, T., Dufour, J.-F., Petta, S., Romero-Gomez, M., Allison, M., Oliveira, C. P., Francque, S., Van Gaal, L., Schattenberg, J. M., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.453 · Cited by 945
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Self-citationSarcopenia from mechanism to diagnosis and treatment in liver disease
Dasarathy, S., & Merli, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.040 · Cited by 608
Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C. (2010) · Diabetes Care · doi:10.2337/dc10-0107 · Cited by 588
Research works printed but not linked: 23
- Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes., Hepatology, 64, 73, 10.1002/hep.28431 · DOI · Paper page
- Non-alcoholic Fatty Liver Disease Study, 2015, Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups., Digest Liver Dis, 47, 997, 10.1016/j.dld.2015.08.004 · DOI · Paper page
- Byrne, 2015, NAFLD: a multisystem disease., J Hepatol, 62, S47, 10.1016/j.jhep.2014.12.012 · DOI · Paper page
- Janssen, 2011, The epidemiology of sarcopenia., Clin Geriatr Med, 27, 355, 10.1016/j.cger.2011.03.004 · DOI · Paper page
- Kim, 2014, Cardiometabolic implication of sarcopenia: The Korea National Health and Nutrition Examination Study (KNHANES) 2008–2010., IJC Metab Endocr, 4, 63, 10.1016/j.ijcme.2014.06.001 · DOI · Paper page
- Sinclair, 2016, Review article: sarcopenia in cirrhosis–aetiology, implications and potential therapeutic interventions., Aliment Pharmacol Ther, 43, 765, 10.1111/apt.13549 · DOI · Paper page
- Lee, 2015, Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008–2011)., J Hepatol, 63, 486, 10.1016/j.jhep.2015.02.051 · DOI · Paper page
- Lee, 2016, Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008–2011)., Hepatology, 63, 776, 10.1002/hep.28376 · DOI · Paper page
- Issa, 2014, Presence of sarcopenia (muscle wasting) in patients with nonalcoholic steatohepatitis., Hepatology, 60, 428, 10.1002/hep.26908 · DOI · Paper page
- Petta, 2017, Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease., Aliment Pharmacol Ther, 45, 510, 10.1111/apt.13889 · DOI · Paper page
- Kim, 2017, Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States., PLoS One, 12, e0186702, 10.1371/journal.pone.0186702 · DOI
- Ruhl, 2005, Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population., Clin Gastroenterol Hepatol, 3, 1260, 10.1016/S1542-3565(05)00743-3 · DOI · Paper page
- Obisesan, 2012, Association of leisure-time physical activity with cognition by apolipoprotein-E genotype in persons aged 60 years and over: the National Health and Nutrition Examination Survey (NHANES-III)., Clin Interv Aging, 7, 35, 10.2147/CIA.S26794 · DOI
- Angulo, 2007, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD., Hepatology, 45, 846, 10.1002/hep.21496 · DOI · Paper page
- Foley, 2007, Kidney function and sarcopenia in the United States general population: NHANES III., Am J Nephrol, 27, 279, 10.1159/000101827 · DOI · Paper page
- 1994, Plan and Operation of the NHANES III, 1988–94, National Center for Health Statistics., Vital Health Stat, 1
- Musso, 2011, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity., Ann Med, 43, 617, 10.3109/07853890.2010.518623 · DOI · Paper page
- Belarmino, 2017, Phase angle obtained by bioelectrical impedance analysis independently predicts mortality in patients with cirrhosis., World J Hepatol, 9, 401, 10.4254/wjh.v9.i7.401 · DOI · Paper page
- Bhanji, 2017, Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in NASH., Hepatology, 66, 2055, 10.1002/hep.29420 · DOI · Paper page
- Kato, 2015, Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver disease., J Diabetes Investig, 6, 158, 10.1111/jdi.12271 · DOI · Paper page
- Ballestri, 2017, Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases., Metabolism, 72, 57, 10.1016/j.metabol.2017.04.003 · DOI · Paper page
- 2017, AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions., Dig Liver Dis, 49, 471, 10.1016/j.dld.2017.01.147 · DOI · Paper page
- Wong, 2018, Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: definition, risk factors and assessment., J Gastroenterol Hepatol, 33, 70, 10.1111/jgh.13857 · DOI · Paper page
Cited by
Cai, C., Song, X., Chen, Y., Chen, X., & Yu, C. (2020) · Hepatology International · doi:10.1007/s12072-019-09964-1 · Cited by 118
Nachit, M., De Rudder, M., Thissen, J., Schakman, O., Bouzin, C., Horsmans, Y., Vande Velde, G., & Leclercq, I. A. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12646 · Cited by 82
Interaction between sarcopenia and nonalcoholic fatty liver disease
Joo, S. K., & Kim, W. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0358 · Cited by 78
Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity
Wijarnpreecha, K., Panjawatanan, P., Aby, E., Ahmed, A., & Kim, D. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.03.016 · Cited by 32
Self-citationNonalcoholic fatty liver disease and sarcopenia: Where do we stand?
Mikolasevic, I., Pavic, T., Filipec Kanizaj, T., Bender, D. V., Domislovic, V., & Krznaric, Z. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/8859719 · Cited by 30
Metadata
- Authors
- Wijarnpreecha, K., Kim, D., Raymond, P., Scribani, M., & Ahmed, A.
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 2019-09
- Volume
- 31
- Issue
- 9
- Pages
- 1121-1128
- ISSN
- 0954-691X (ISSN-L)
- OpenAlex
- W2924915225
- Cited by
- 70
- References
- 15
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA. https://app.cochat.ai/papers/10.1097/meg.0000000000001397
- The paper
- Wijarnpreecha, K., Kim, D., Raymond, P., Scribani, M., & Ahmed, A. (2019). Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000001397
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.